Bile Salt Export Pump Gene Mutations in Two Japanese Patients With Progressive Familial Intrahepatic Cholestasis
- 1 May 2003
- journal article
- case report
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 36 (5) , 647-650
- https://doi.org/10.1097/00005176-200305000-00012
Abstract
In recent years, progressive familial intrahepatic cholestasis has been classified into at least three types by genetic analysis: PFIC1, PFIC2, and MDR3. Liver transplantation is effective for treating patients with this intractable syndrome. Confirming the correct diagnosis is of paramount importance because prognosis after transplantation differs with the genetic type of the disease. Synthesis of cDNA was accomplished using RNA extracted from liver tissue of two Japanese patients with progressive familial intrahepatic cholestasis. Polymerase chain reaction was performed using 13 primer sets designed for amplification of the bile salt export pump cDNA. Direct sequencing was undertaken, and identified sequences were compared with the sequence for bile salt export pump gene registered with GenBank. In addition, gene sequences for nonprogressive familial intrahepatic cholestasis patients were analyzed. Genetic analysis of patient 1 revealed that substitutions in bile salt export pump protein sequences, namely R575X and E636G, might be the cause of the disease. In patient 2, V330X and R487H might fulfill the same role. Results of gene analysis in parents and cholestatic controls supported these conclusions. Absence or presence of bile salt export protein gene mutations was confirmed as representing a useful prognostic marker for clinical course after liver transplantation.Keywords
This publication has 12 references indexed in Scilit:
- Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasisGastroenterology, 1999
- A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasisNature Genetics, 1998
- A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasisNature Genetics, 1998
- Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasisProceedings of the National Academy of Sciences, 1998
- Identification of a Locus for Progressive Familial Intrahepatic Cholestasis PFIC2on Chromosome 2q24American Journal of Human Genetics, 1997
- Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-q22Human Genetics, 1997
- Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneityHepatology, 1997
- A Subfamily of P-Type ATPases with Aminophospholipid Transporting ActivityScience, 1996
- Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasisHepatology, 1996
- Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis regionHuman Molecular Genetics, 1995